Baidu
map

2019 ASCO临床实践指南:已切除胆管癌的辅助治疗

2019-03-11 美国临床肿瘤学会

以证据为基础的临床实践指南,协助胆管癌切除患者的临床决策。

中文标题:

2019 ASCO临床实践指南:已切除胆管癌的辅助治疗

英文标题:

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

发布机构:

美国临床肿瘤学会

发布日期:

2019-03-11

简要介绍:

以证据为基础的临床实践指南,协助胆管癌切除患者的临床决策。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ASCO临床实践指南:已切除胆管癌的辅助治疗)] GetToolGuiderByIdResponse(projectId=1, id=c62b71c001e67863, title=2019 ASCO临床实践指南:已切除胆管癌的辅助治疗, enTitle=Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline, guiderFrom=, authorId=null, author=, summary=以证据为基础的临床实践指南,协助胆管癌切除患者的临床决策。, cover=, journalId=null, articlesId=null, associationId=8, associationName=美国临床肿瘤学会, associationIntro=美国临床肿瘤学会(ASCO,American Society of Clinical Oncology)是一个成立于1964年的非营利性组织,总目标是改善肿瘤的监护与预防。目前已有27000名肿瘤科医师加入了ASCO,分属各个肿瘤专科和亚专科。会员包括在肿瘤治疗各个层次的医师和卫生保健专业人员。ASCO由一个有19名成员的当选董事会管理,该学会的大部分业务是由志愿为学会项目花费时间和出力的ASCO会员组成的各种委员会处理的。患者支持团体的领导也经常活跃于ASCO委员会中。目前有22个由ASCO的全职人员管理和支持的委员会。, copyright=0, guiderPublishedTime=Mon Mar 11 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<span style="color: rgb(46, 48, 51); font-family: Arial, 'Microsoft YaHei', 微软雅黑, 宋体, 'Malgun Gothic', Meiryo, sans-serif; font-size: 14px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 18px; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none;">以证据为基础的临床实践指南,协助胆管癌切除患者的临床决策。</span>, tagList=[], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3095, appHits=340, showAppHits=16, pcHits=1754, showPcHits=1877, likes=56, shares=9, comments=12, approvalStatus=1, publishedTime=Fri Jul 26 16:36:42 CST 2019, publishedTimeString=2019-03-11, pcVisible=1, appVisible=1, editorId=5296140, editor=Vina2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=Vina2, createdTime=Fri Jul 26 16:36:42 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:31:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ASCO临床实践指南:已切除胆管癌的辅助治疗)])
2019 ASCO临床实践指南:已切除胆管癌的辅助治疗
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台,受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910083, encodeId=f543910083d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ro8ALJAlzJA1mY40SqxVqhwvJG08PQj1UfqwzfpLFUtSQ8a9XR7mdtHibo4icbHUZUFW7rkAahUPryAiccm2fgQ9A/132, createdBy=5a475276174, createdName=糕糕糕, createdTime=Tue Dec 22 14:39:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2022-06-23 145d4c03m99暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台,受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910083, encodeId=f543910083d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ro8ALJAlzJA1mY40SqxVqhwvJG08PQj1UfqwzfpLFUtSQ8a9XR7mdtHibo4icbHUZUFW7rkAahUPryAiccm2fgQ9A/132, createdBy=5a475276174, createdName=糕糕糕, createdTime=Tue Dec 22 14:39:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2021-02-24

    内容已损坏 ?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台,受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910083, encodeId=f543910083d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ro8ALJAlzJA1mY40SqxVqhwvJG08PQj1UfqwzfpLFUtSQ8a9XR7mdtHibo4icbHUZUFW7rkAahUPryAiccm2fgQ9A/132, createdBy=5a475276174, createdName=糕糕糕, createdTime=Tue Dec 22 14:39:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2021-02-24

    谢谢平台提供这么方便的学习平台,受教了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台,受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910083, encodeId=f543910083d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ro8ALJAlzJA1mY40SqxVqhwvJG08PQj1UfqwzfpLFUtSQ8a9XR7mdtHibo4icbHUZUFW7rkAahUPryAiccm2fgQ9A/132, createdBy=5a475276174, createdName=糕糕糕, createdTime=Tue Dec 22 14:39:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2021-01-20 12539c47m51暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1228242, encodeId=41ea122824284, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:32 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926781, encodeId=6127926e819d, content=内容已损坏 ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:51 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926780, encodeId=a74f926e8083, content=谢谢平台提供这么方便的学习平台,受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:44:00 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918288, encodeId=fa1d918288ab, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/18/4904f1f58fd84759f4600a01d3817b4f.jpg, createdBy=f68b2548802, createdName=12539c47m51暂无昵称, createdTime=Wed Jan 20 09:33:54 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910083, encodeId=f543910083d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ro8ALJAlzJA1mY40SqxVqhwvJG08PQj1UfqwzfpLFUtSQ8a9XR7mdtHibo4icbHUZUFW7rkAahUPryAiccm2fgQ9A/132, createdBy=5a475276174, createdName=糕糕糕, createdTime=Tue Dec 22 14:39:50 CST 2020, time=2020-12-22, status=1, ipAttribution=)]
    2020-12-22 糕糕糕

    学习

    0

Baidu
map
Baidu
map
Baidu
map